Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients by Eman M. F. Barakat, Mohamed Kohla, Hossam Dabees, Hend Ibrahim Shousha, Ehab F. Moustafa, Mohamed El-Kassas, Mona Shoukry Aziz, Eman Elkhateeb, Ashraf Omar Abdelaziz, Mohamed Omar Abdelmalek, Aly Azmy, Ahmed Tawheed, Walaa Mosaad Aboganob, Hossam Taha, Rania Lithy, Ahmed Radwan, Dalia Ghoraba, Hamdy Sayed, Anwar Nassief, Mostafa Elhelbawy, Mohamed Mahmoud nabeel, Mohamed A. Medhat, Safaa Ragab Askar, Eman Marwan, Eman Rewisha, Tamer Elbaz, Sayed Hassan Ahmed, Nevien Fouad elfouly, Nermeen Abdeen, Ahmed Hosni Abdelmaksoud, Asmaa A. Abdeltawab, Mostafa Abd Alfattah Shamkh, Ahmed Ramadan, Yasser Arafat Abdelrazek, Mohamed Bassam, Sayed Ahmed Sayed, Rasha Salah Hussein, Ammar Alrajhi, Allam Elsayed Allam, Omnia A. Seyam, Mohamed Said

Get full text